HOME >> BIOLOGY >> NEWS
AAAS CEO Alan I. Leshner statement on the UN cloning debate

Washington, DC -- A statement from Dr. Alan I. Leshner, CEO of the American Association for the Advancement of Science and executive publisher of the journal Science, on the debate over research cloning that is scheduled to begin at the United Nations on Thursday 21 October 2004:

"We realize that this issue generates intense debate. We have long opposed human cloning to produce babies as dangerous and irresponsible. But we believe that nuclear cell transplantation research - what is called research or therapeutic cloning - holds the potential to ease tremendous suffering and prolong life for countless millions of people. For that reason, this window of scientific and eventual clinical opportunity should not be shut prematurely.

"These positions are reflected in the measure sponsored by Belgium-a measure that clearly represents the mainstream of scientific and medical thinking in the United States and worldwide."


'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
20-Oct-2004


Page: 1

Related biology news :

1. Statement from Dr. Alan I. Leshner, CEO of AAAS, on the Kansas State Board of Education vote
2. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
3. AAAS CEO Alan I. Leshner registers strong concerns over suppression of science films
4. AAAS CEO Alan I. Leshner welcomes proposed Washington state legislation on stem cell research
5. Science academies issue statements on energy efficiency, innovation
6. AAAS releases video and first board consensus statement on climate change
7. Draft environmental impact statement prepared for USAMRIID facilities at Fort Detrick
8. Environmental impact statement planned for USAMRIID facilities at Fort Detrick
9. The AIUM releases new statement regarding keepsake imaging
10. AGU statement on future of Earth and space science research at NASA
11. Amgens decision to block reinstatement of GDNF is faulted by a leading Parkinsons advocacy group

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)...   Bridge Patient Portal , an enterprise ... EMR Systems , an electronic medical record solutions ... established a partnership to build an interface between ... Centricity™ products, including Centricity Practice Solution (CPS), Centricity ... new integrations will allow healthcare delivery networks using ...
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext Inc., a global ... of a media edge server, the M820, which features the company,s ... recognition software provided by Tera Probe, Inc., will be showcased during ... at the NAB show at the Las Vegas ... ...
(Date:4/11/2017)... BEACH GARDENS, Fla. , April 11, 2017 ... identity management and secure authentication solutions, today announced ... contract by Intelligence Advanced Research Projects Activity (IARPA) ... for IARPA,s Thor program. "Innovation has ... onset and IARPA,s Thor program will allow us ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... of a United States multicenter, prospective clinical study that demonstrates the accuracy ... test capable of identifying clinically significant acute bacterial and viral respiratory tract ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology:
Cached News: